Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in sierra leone prior to the 2014 outbreak

Viral Immunology

Volumn 28, Issue 1, 2015, Pages 19-31

  Boisen, Matthew L ^a,b   Schieffelin, John S ^b   Goba, Augustine ^c   Oottamasathien, Darin ^a   Jones, Abigail B ^a   Shaffer, Jeffrey G ^d   Hastie, Kathryn M ^e   Hartnett, Jessica N ^b   Momoh, Mambu ^c   Fullah, Mohammed ^c   Gabiki, Michael ^c   Safa, Sidiki ^c   Zandonatti, Michelle ^e   Fusco, Marnie ^e   Bornholdt, Zach ^e   Abelson, Dafna ^e   Gire, Stephen K ^f,g   Andersen, Kristian G ^f,g   Tariyal, Ridhi ^f,g   Stremlau, Mathew ^f,g   Cross, Robert W ^b,h   Geisbert, Joan B ^h   Pitts, Kelly R ^a   Geisbert, Thomas W ^h   Kulakoski, Peter ⁱ   Wilson, Russell B ⁱ   Henderson, Lee ^j   Sabeti, Pardis C ^f,g,k   Grant, Donald S ^c   Garry, Robert F ^b,l   Saphire, Erica O ^e   Branco, Luis M ^i,l   Khan, Sheik Humarr ^c   more..

^a Division of Medicine   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ministry of Health and Sanitation   (Sierra Leone)

^d TULANE UNIVERSITY   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f HARVARD UNIVERSITY   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h University of Texas Medical Branch School of Medicine   (United States)

ⁱ Autoimmune Technologies LLC   (United States)

^j Vybion Inc   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l Zalgen Labs   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA; BACTERIUM ANTIBODY; PROTOZOAL DNA; VIRUS ANTIBODY;

AMPLICON; ARTICLE; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; DENGUE VIRUS; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FILOVIRUS; FILOVIRUS INFECTION; HEMORRHAGIC FEVER; HUMAN; LASSA FEVER; LEPTOSPIRA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; POLYMERASE CHAIN REACTION; SEROPREVALENCE; SIERRA LEONE; TYPHUS; VIRUS DETECTION; WEST NILE FLAVIVIRUS; BLOOD; EPIDEMIC; HEMORRHAGIC FEVERS, VIRAL; PATHOLOGY; RETROSPECTIVE STUDY;

CHIKUNGUNYA VIRUS; DENGUE VIRUS; EBOLA VIRUS; LASSA VIRUS; LEPTOSPIRA; PLASMODIUM FALCIPARUM; WEST NILE VIRUS;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DISEASE OUTBREAKS; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVERS, VIRAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SIERRA LEONE;

EID: 84920771162     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0108     Document Type: Article

References (46)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014;371: 1418-1425.
2. Barzon L, Lavezzo E, Militello V, et al. Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 2011;12:7861-7884.
3. Bausch DG, and Schwarz L. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 2014;8:e3056.
4. Bausch DG, Sesay SS, and Oshin B. On the front lines of Lassa fever. Emerg Infect Dis 2004;10:1889-1890.
5. Becker S, Feldmann H, Will C, et al. Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol 1992;181:43-55.
6. Becquart P, Wauquier N,Mahlakoiv T, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010;5:e9126.
7. Bertherat E, Renaut A, Nabias R, et al. Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. Am J Trop Med Hyg 1999;60:610-615.
8. Bodewes R, Kik MJ, Raj VS, et al. Detection of novel divergent arenaviruses in boid snakes with inclusion body disease in the Netherlands. J Gen Virol 2013;94:1206-1210.
9. Bond N, Schieffelin JS, Moses LM, et al. A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Am J Trop Med Hyg 2012;88: 241-244.
10. Bornholdt ZA, Noda T, Abelson DM, et al. Structural rearrangement of Ebola virus VP40 begets multiple functions in the virus life cycle. Cell 2013;154:763-774.
11. Branco LM, Boisen ML, Andersen KG, et al. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virol J 2011;8:404.
12. Branco LM, Grove JN, Boisen ML, et al. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J 2011; 8:478
13. Branco LM, Matschiner A, Fair JN, et al. Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol J 2008;5:74.
14. Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg 1970;19:680-691.
15. Capobianchi MR, Giombine E, and Rozera G. Next-generation sequencing technology in clinical virology. Clin Microbiol Infect 2013;19:15-22.
16. Carletti F, Bordi L, Chiappini R, et al. Rapid detection and quantification of Chikungunya virus by a one-step reverse transcription polymerase chain reaction real-time assay. Am J Trop Med Hyg 2007;77:521-524.
17. Da Silva NS, Da Silva-Nunes M, Malafronte RS, et al. Epidemiology and control of frontier malaria in Brazil: lessons from community-based studies in rural Amazonia. Trans R Soc Trop Med Hyg 2010;104:343-350.
18. Demby AH, Chamberlain J, Brown DW, et al. Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol 1994;32:2898-2903.
19. Dixon MG, and Schafer IJ. Ebola viral disease outbreak-West Africa, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:548-551.
20. Drosten C, Gottig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002;40:2323-2330.
21. Feldmann H. Ebola-A growing threat? N Engl J Med 2014;371:1375-1378.
22. Formenty P, Boesch C, Wyers M, et al. Ebola virus outbreak among wild chimpanzees living in a rain forest of Cote d'Ivoire. J Infect Dis 1999;179:S120-126.
23. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014;345:1369-1372.
24. Grove JN, Branco LM, Boisen ML, et al. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J 2011;8:314.
25. Gunther S, Asper M, Roser C, Luna LK, Drosten C, Becker-Ziaja B, Borowski P, Chen HM, Hosmane RS. Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro. Antiviral Res 2004;63:209-215.
26. Hensley LE, Smith MA, Geisbert JB, et al. Pathogenesis of Lassa fever in cynomolgus macaques. Virol J 2011; 8:205.
27. Huggins JW. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 1989;11:S750-761.
28. Jiang J, Temenak JJ, and Richards AL. Real-time PCR duplex assay for Rickettsia prowazekii and Borrelia recurrentis. Ann N Y Acad Sci 2003;990:302-310.
29. Keane E, and Gilles HM. Lassa fever in Panguma Hospital, Sierra Leone, 1973-6. Br Med J 1977;1:1399-1402.
30. Khan SH, Goba A, Chu M, et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 2008;78:103-115.
31. Lee JE, Fusco ML, Hessell AJ, et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008;454:177-182.
32. Mahanty S, Bausch DG, Thomas RL, et al. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis 2001;183:1713-1721.
33. Malhotra S, Yen JY, Honko AN, et al. Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure. PLoS Negl Trop Dis 2013; 7:e2171.
34. McCormick JB, Webb PA, Krebs JW, et al. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987;155:437-444.
35. Monath TP, Maher M, Casals J, et al. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 1974;23:1140-1149.
36. Mourya DT, Yadav PD, Shete AM, et al. Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010-2011. PLoS Negl Trop Dis 2012;6:e1653.
37. Olschlager S, Lelke M, Emmerich P, et al. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5¢ region of S RNA. J Clin Microbiol 2010;48:2009-2013.
38. Park SH, Kim HJ, Cho WH, et al. Identification of Salmonella enterica subspecies I, Salmonella enterica serovars Typhimurium, Enteritidis and Typhi using multiplex PCR. FEMS Microbiol Lett 2009;301:137-146.
39. Reitstetter RE. Development of species-specific PCR primer sets for the detection of Leptospira. FEMS Microbiol Lett 2006;264:31-39.
40. Schoepp RJ, Rossi CA, Khan SH, et al. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis 2014;20:1176-1182.
41. Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis 2014;8:e2748.
42. Shirato K, Miyoshi H, Kariwa H, et al. Detection of West Nile virus and Japanese encephalitis virus using real-time PCR with a probe common to both viruses. J Virol Methods 2005;126:119-125.
43. Snell NJ. Ribavirin-current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2001;2:1317-1324.
44. Wang J, Selleck P, Yu M, et al. Novel phlebovirus with zoonotic potential isolate from ticks, Australia. Emerg Inf Dis 2014;20:1040-1043.
45. Watts GM. Lily Lyman Pinneo. Lancet 2013;380:1552.
46. WHO: Ebola Response Roadmap Situation Report November 26, 2014. Available at http://apps.who.int/iris/bitstream/10665/144498/1/roadmapsitrep-26Nov2014-eng.pdf?ua = 1 (accessed December 2, 2014).